McNeil Consumer Healthcarecan increase its OTC drug manufacturing capacity as FDA signs off on remediation of the Johnson & Johnson subsidiary’s headquarters facility that was closed under a consent decree.
J&J/McNeil Completes Remediation Under Consent Decree
FDA officials on Aug. 21 notified the firm that its Fort Washington, Pa., manufacturing plant is compliant with the agency’s GMP regulations for drugs.